Submit Manuscript  

Article Details


The Research Progress of Direct Thrombin Inhibitors

Author(s):

Zhi-Gang Sun, Yang-Liu, Jin-Mai Zhang, Shi-Chang Cui, Zhi-Gang Zhang and Hai-Liang Zhu*   Pages 1 - 11 ( 11 )

Abstract:


Blood coagulation is the process of changing the blood from the flowing state to the gel state. It is an important part of the hemostatic function. Coagulation is a process by which a series of coagulation factors are sequentially activated, and finally thrombin is formed to form fibrin clot. Direct thrombin inhibitors are important anticoagulant drug. These drugs can selectively bind to the active site of thrombin, inhibit thrombin activity, have strong action and high specificity, and have important significance in the clinical treatment of thrombus diseases. Some of them come from natural products of animals or plants, and many of them have been applied in clinic. The other part is derived from the design, synthesis and activity studies of small molecule inhibitors. This review discusses the progress of direct thrombin inhibitors in recent years.

Keywords:

Thrombin inhibitor, natural product, blood coagulation, dabigatran, pyridine, benzofuran

Affiliation:

Central Laboratory, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, Central Laboratory, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, Room 205, BIO-X white house, Shanghai Jiao Tong University, No.1954 Huashan Road, Shanghai 200030, Central Laboratory, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, Department of Cardiovascular Medicine, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No.163 Xianlin Road, Nanjing 210023



Read Full-Text article